About Surecare Pharma Private Limited
Data last updated:
Surecare Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 November 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC123215. Its GSTIN is 07AAHCS8606C1ZF (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Savita Katara and Prashant Katara.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wz – 97B Shop No – 20 Ist Floor Tek Chand Complex Jwala Heri Paschim Vihar, New Delhi, Delhi, India – 110063.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.74 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹3.9 Lakh (net margin -2.2%) and EBITDA of ₹12.09 Lakh (EBITDA margin 6.9%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹48.14 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surecarepharma.com.
Company details
Contact details
Surecare Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is surecarepharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressWz – 97B Shop No – 20 Ist Floor Tek Chand Complex Jwala Heri Paschim Vihar, New Delhi, Delhi, India – 110063
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Surecare Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Surecare Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Surecare Pharma Private Limited, buy the company report.
Financials of Surecare Pharma Private Limited
FY 2025 filings availableSurecare Pharma Private Limited reported revenue of ₹1.74 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 123% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.74 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.9% | ||||
| Net Profit Margin | -2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Surecare Pharma Private Limited, buy the company report.
Board of directors of Surecare Pharma Private Limited
Surecare Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Savita Katara | Director | 25 Nov 2003 | 22 Years 11 Months | Current |
| Prashant Katara | Director | 25 Jun 2019 | 7 Years 4 Months | Current |
Peer comparison
Surecare Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Elvey Essentials Private Limited | ₹1.75 Cr (FY 2025) | 190.0% | Indore, Madhya Pradesh, India | |||
| Srisahith Enterprise (OPC) Private Limited | ₹1.75 Cr (FY 2025) | 44.0% | Aruppukottai, Tamil Nadu, India | |||
| Kalpa Healthcare Private Limited | ₹1.75 Cr (FY 2024) | 4.0% | Chennai, Tamil Nadu, India | |||
| Surecare Pharma Private Limitedthis company | ₹1.74 Cr (FY 2025) | -₹3.9 Lakh | -2.2% | 3.0% | New Delhi, Delhi, India | |
| Nilachala Medi Point Private Limited | ₹1.74 Cr (FY 2025) | 90.0% | Bhubaneswar, Odisha, India | |||
| Medicate International Private Limited | ₹1.74 Cr (FY 2024) | -36.0% | New Delhi, Delhi, India |
To see the full peer comparison of Surecare Pharma Private Limited, buy the company report.
Auditor
Surecare Pharma Private Limited is audited by V SAHAI TRIPATHI & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V SAHAI TRIPATHI & CO | FY 2022 | 000262N |
Shareholding
The shareholding of Surecare Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Surecare Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2024 | 100921851 | Hdfc Bank Limited | ₹14.89 Lakh | Open | |
| 01 Nov 2022 | 100644732 | Others | ₹25 Lakh | Open | |
| 18 Dec 2019 | 100314756 | Others | ₹8.25 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Surecare Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Surecare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Surecare Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCS8606C1ZF | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Surecare Pharma Private Limited, buy the company report.
Recent activity
Surecare Pharma Private Limited has 3 board changes on record since 2003: 2 appointments and 1 cessation. The latest: Prashant Katara was appointed as Director on 25 Jun 2019.
Frequently asked questions
Surecare Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 November 2003 (23+ years old) and is registered under CIN U24239DL2003PTC123215.
Surecare Pharma has 2 current directors:
- Savita Katara - Director
- Prashant Katara - Director
The latest financial statements of Surecare Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Surecare Pharma is 07AAHCS8606C1ZF, registered in Delhi.
The CIN (Corporate Identification Number) of Surecare Pharma is U24239DL2003PTC123215. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Surecare Pharma was incorporated on 25 November 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Surecare Pharma by revenue are Elvey Essentials Private Limited, Srisahith Enterprise (OPC) Private Limited, Kalpa Healthcare Private Limited, Nilachala Medi Point Private Limited, Medicate International Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Prashant Katara was appointed as Director on 25 Jun 2019. Prashant Katara ceased to be Director on 20 Jun 2019. Savita Katara was appointed as Director on 25 Nov 2003.
Surecare Pharma can be reached through the website surecarepharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Surecare Pharma is at Wz – 97B Shop No – 20 Ist Floor Tek Chand Complex Jwala Heri Paschim Vihar, New Delhi, Delhi, India – 110063.
Surecare Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
